<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01266122</url>
  </required_header>
  <id_info>
    <org_study_id>5R21MH085314-02</org_study_id>
    <secondary_id>5R21MH085314-02</secondary_id>
    <nct_id>NCT01266122</nct_id>
  </id_info>
  <brief_title>Addressing Psychosocial Needs and HIV Risk in Indian MSM</brief_title>
  <official_title>Addressing Psychosocial Needs and HIV Risk in Indian MSM</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Mental Health (NIMH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tuberculosis Research Centre, India</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fenway Community Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will develop and pilot test a combined individual and group-level behavioral HIV
      prevention intervention for men who have sex with men (MSM) in Chennai, India, addressing HIV
      risk within the context of broader psychosocial issues, including self-acceptance, substance
      use and social support.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      MSM in India are at increased risk for HIV in a stigmatizing environment that includes
      discrimination and violence. There is a need for evidence-based MSM HIV prevention
      interventions that address HIV risk in the context of these psychosocial issues. This study
      consists of formative qualitative work followed by the development and testing of a pilot
      behavioral HIV prevention intervention for MSM in Chennai, India. Study goals are to maximize
      intervention feasibility and acceptability, estimate an effect size for a power analysis, and
      prepare for a full-scale trial to follow.

      PHASE 1-Intervention Development. This phase involved the collection of formative data
      through MSM focus groups and key informant interviews to develop a subsequent pilot
      behavioral intervention.

      PHASE 2-Open Pilot. Following Phase 1, the team conducted an open-phase non-randomized pilot
      of the intervention. Enrollment involved a baseline assessment that included an
      interviewer-administered behavioral assessment and voluntary counseling and testing for HIV
      and the STIs, syphilis, gonorrhea and chlamydia. Eleven MSM in Chennai then completed 6 group
      sessions and 4 individual sessions over 3 months. A follow-up behavioral assessment was
      administered upon completion of all sessions, and 6 months after baseline participants were
      again administered the questionnaire and HIV/STI testing.

      PHASE 3-Pilot Randomized Controlled Trial. The study is currently in Phase 3, and the data
      articulated in this registry is for Phase 3. We are now conducting a pilot randomized
      controlled trial (RCT) of the intervention among 6 &quot;batches&quot; of 8 MSM in each group (n=48).
      Comparison groups (n=48) will receive the same baseline assessment and voluntary HIV/STI
      counseling and testing as the intervention groups. Based on Phase 2 findings, the
      intervention groups will meet for 4 group sessions and 4 individual sessions. Those assigned
      to receive the comparison condition will not receive these sessions. Participants complete
      the assessments approximately 3 months after randomization, and again 3 months after that.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">November 2010</completion_date>
  <primary_completion_date type="Actual">November 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in HIV Risk Taking Behavior - Number of Condomless Sex Acts Per Participant</measure>
    <time_frame>up to 6 months</time_frame>
    <description>We will examine sexual risk taking among the sample using self-report (interviewer administered) measures.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Acquisition of STIs - Number of Participants That Acquired STIs</measure>
    <time_frame>6 months</time_frame>
    <description>We will test for locally relevant STIs at baseline and 6 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Psychosocial Mediators</measure>
    <time_frame>up to 6 months</time_frame>
    <description>We will examine the degree to which hypothesized mediators change differentially across the experimental and control arms.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">96</enrollment>
  <condition>HIV/STI Risk</condition>
  <condition>HIV/STI Incidence</condition>
  <arm_group>
    <arm_group_label>HIV/STI voluntary counseling and testing</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants enrolled in the control arm will receive study assessments only.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Behavioral intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants enrolled in the experimental condition will receive 4 group sessions and 4 individual sessions over 3 months. This intervention focuses on psychosocial concerns and HIV risk for MSM in India.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Behavioral intervention</intervention_name>
    <description>The behavioral intervention will consist of 4 group sessions and 4 individual sessions over 3 months. The overall focus is on psychosocial concerns and HIV risk.</description>
    <arm_group_label>Behavioral intervention</arm_group_label>
    <other_name>Psychosocial intervention for MSM in India</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Man who has had unprotected sex with another man in past 3 months

          -  Resident of Tamil Nadu state, India

          -  Identifies as Khothi or Double-decker

        Exclusion Criteria:

          -  Does not identify as a man (i.e. Hijra/ Ali/Transgendered)

          -  Under age 18

          -  Unable to complete or understand informed consent procedures
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven A. Safren, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital, Boston, Massachusetts, United States</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Beena E. Thomas, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tuberculosis Research Centre, Chennai, India</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fenway Community Health</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tuberculosis Research Centre</name>
      <address>
        <city>Chennai</city>
        <state>Tamil Nadu</state>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 24, 2010</study_first_submitted>
  <study_first_submitted_qc>December 22, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 24, 2010</study_first_posted>
  <results_first_submitted>August 4, 2014</results_first_submitted>
  <results_first_submitted_qc>May 14, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 1, 2015</results_first_posted>
  <last_update_submitted>May 14, 2015</last_update_submitted>
  <last_update_submitted_qc>May 14, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 1, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Steven A. Safren</investigator_full_name>
    <investigator_title>Director, Behavioral Medicine</investigator_title>
  </responsible_party>
  <keyword>HIV</keyword>
  <keyword>Psychosocial problems</keyword>
  <keyword>MSM</keyword>
  <keyword>India</keyword>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>HIV/STI Voluntary Counseling and Testing</title>
          <description>Participants enrolled in the control arm will receive study assessments only.</description>
        </group>
        <group group_id="P2">
          <title>Behavioral Intervention</title>
          <description>Participants enrolled in the experimental condition will receive 4 group sessions and 4 individual sessions over 3 months. This intervention focuses on psychosocial concerns and HIV risk for MSM in India.
Behavioral intervention: The behavioral intervention will consist of 4 group sessions and 4 individual sessions over 3 months. The overall focus is on psychosocial concerns and HIV risk.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="48"/>
                <participants group_id="P2" count="48"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="42"/>
                <participants group_id="P2" count="42"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>HIV/STI Voluntary Counseling and Testing</title>
          <description>Participants enrolled in the control arm will receive study assessments only.</description>
        </group>
        <group group_id="B2">
          <title>Behavioral Intervention</title>
          <description>Participants enrolled in the experimental condition will receive 4 group sessions and 4 individual sessions over 3 months. This intervention focuses on psychosocial concerns and HIV risk for MSM in India.
Behavioral intervention: The behavioral intervention will consist of 4 group sessions and 4 individual sessions over 3 months. The overall focus is on psychosocial concerns and HIV risk.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="48"/>
            <count group_id="B2" value="48"/>
            <count group_id="B3" value="96"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29.7" spread="8.1"/>
                    <measurement group_id="B2" value="28.4" spread="6.9"/>
                    <measurement group_id="B3" value="29" spread="7.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                    <measurement group_id="B2" value="48"/>
                    <measurement group_id="B3" value="96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Changes in HIV Risk Taking Behavior - Number of Condomless Sex Acts Per Participant</title>
        <description>We will examine sexual risk taking among the sample using self-report (interviewer administered) measures.</description>
        <time_frame>up to 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>HIV/STI Voluntary Counseling and Testing</title>
            <description>Participants enrolled in the control arm will receive study assessments only.</description>
          </group>
          <group group_id="O2">
            <title>Behavioral Intervention</title>
            <description>Participants enrolled in the experimental condition will receive 4 group sessions and 4 individual sessions over 3 months. This intervention focuses on psychosocial concerns and HIV risk for MSM in India.
Behavioral intervention: The behavioral intervention will consist of 4 group sessions and 4 individual sessions over 3 months. The overall focus is on psychosocial concerns and HIV risk.</description>
          </group>
        </group_list>
        <measure>
          <title>Changes in HIV Risk Taking Behavior - Number of Condomless Sex Acts Per Participant</title>
          <description>We will examine sexual risk taking among the sample using self-report (interviewer administered) measures.</description>
          <units>number of unprotected sex acts</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="48"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.58" spread="1.36"/>
                    <measurement group_id="O2" value="3.69" spread=".73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Intent to treat analysis</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.001</p_value>
            <method>Mixed Models Analysis</method>
            <method_desc>Mixed effects Poisson regression</method_desc>
            <param_type>log(Incident Risk Ratio)</param_type>
            <param_value>-.95</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.47</ci_lower_limit>
            <ci_upper_limit>-.44</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Acquisition of STIs - Number of Participants That Acquired STIs</title>
        <description>We will test for locally relevant STIs at baseline and 6 months.</description>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>HIV/STI Voluntary Counseling and Testing</title>
            <description>Participants enrolled in the control arm will receive study assessments only.</description>
          </group>
          <group group_id="O2">
            <title>Behavioral Intervention</title>
            <description>Participants enrolled in the experimental condition will receive 4 group sessions and 4 individual sessions over 3 months. This intervention focuses on psychosocial concerns and HIV risk for MSM in India.
Behavioral intervention: The behavioral intervention will consist of 4 group sessions and 4 individual sessions over 3 months. The overall focus is on psychosocial concerns and HIV risk.</description>
          </group>
        </group_list>
        <measure>
          <title>Acquisition of STIs - Number of Participants That Acquired STIs</title>
          <description>We will test for locally relevant STIs at baseline and 6 months.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="48"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Intent to treat analysis.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>=.239</p_value>
            <method>Chi-squared</method>
            <param_type>Chi-square statistic</param_type>
            <param_value>1.39</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes in Psychosocial Mediators</title>
        <description>We will examine the degree to which hypothesized mediators change differentially across the experimental and control arms.</description>
        <time_frame>up to 6 months</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>HIV/STI Voluntary Counseling and Testing</title>
          <description>Participants enrolled in the control arm will receive study assessments only.</description>
        </group>
        <group group_id="E2">
          <title>Behavioral Intervention</title>
          <description>Participants enrolled in the experimental condition will receive 4 group sessions and 4 individual sessions over 3 months. This intervention focuses on psychosocial concerns and HIV risk for MSM in India.
Behavioral intervention: The behavioral intervention will consist of 4 group sessions and 4 individual sessions over 3 months. The overall focus is on psychosocial concerns and HIV risk.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="48"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="48"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Steven Safren</name_or_title>
      <organization>Behavioral Medicine Service, Massachusetts General Hospital</organization>
      <phone>617-724-0817</phone>
      <email>ssafren@partners.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

